Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial

被引：0
|
作者：
Sundin, Ulf [1 ,2 ]
Aga, Anna-Birgitte [1 ]
Skare, Oivind [1 ]
Nordberg, Lena [1 ]
Uhlig, Till [3 ]
Hammer, Hilde [1 ]
van der Heijde, Desiree [4 ]
Kvien, Tore [3 ]
Lillegraven, Siri [1 ]
Haavardsholm, Espen [3 ]
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Univ Oslo, Diakonhjemmet Hosp, Dept Rheumatol, Fac Med, Oslo, Norway
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0280
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial
    Yu, Zhi
    Lu, Bing
    Agosti, Jenifer
    Bitton, Asaf
    Corrigan, Cassandra
    Fraenkel, Liana
    Harrold, Leslie R.
    Losina, Elena
    Katz, Jeffrey N.
    Solomon, Daniel H.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (05) : 801 - 806
  • [2] Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis
    Sundin, Ulf
    Aga, Anna-Birgitte
    Skare, Oivind
    Nordberg, Lena B.
    Uhlig, Till
    Hammer, Hilde B.
    van der Heijde, Desiree
    Kvien, Tore K.
    Lillegraven, Siri
    Haavardsholm, Espen A.
    RHEUMATOLOGY, 2020, 59 (09) : 2550 - 2555
  • [3] ULTRASOUND IN THE MANAGEMENT OF EARLY RHEUMATOID ARTHRITIS: MRI OUTCOME DATA FROM THE ARCTIC RANDOMIZED CONTROLLED STRATEGY TRIAL
    Sundin, Ulf
    Aga, Anna-Birgitte
    Skare, Oivind
    Norberg, Lena B.
    Uhlig, Till
    Hammer, Hilde Berner
    van der Heijde, Desiree
    Kvien, Tore K.
    Lillegraven, Siri
    Haavardsholm, Espen
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 142 - 142
  • [4] Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis The IMAGINE-RA Randomized Clinical Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo
    Hetland, Merete Lund
    Ornbjerg, Lykke Midtboll
    Glinatsi, Daniel
    Moller, Jakob
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agnete H.
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 461 - 472
  • [5] Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo Jannik
    Boesen, Mikael
    Hetland, Merete Lund
    Christensen, Robin
    Moller, Jakob
    Krogh, Niels Steen
    Stengaard-Pedersen, Kristian
    Ostergaard, Mikkel
    TRIALS, 2015, 16
  • [6] Effect of Treat-to-target Strategies Aiming at Remission of Arterial Stiffness in Early Rheumatoid Arthritis: A Randomized Controlled Study
    Tam, Lydia Ho-Pui
    Shang, Qing
    Li, Edmund Kwok-Ming
    Wong, Priscilla Ching-Han
    Kwok, Kitty Yan
    Kun, Emily Wai-Lin
    Yim, Isaac Cheuk-Wan
    Lee, Violet Ka-Lai
    Yip, Ronald Man-Lung
    Pang, Steve Hin-Ting
    Lao, Virginia Weng-Nga
    Mak, Queenie Wah-Yan
    Cheng, Isaac Tsz-Ho
    Lau, Xerox Sze-Lok
    Li, Tena Ka-Yan
    Zhu, Tracy Yaner
    Lee, Alex Pui-Wai
    Tam, Lai-Shan
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (09) : 1229 - 1239
  • [7] Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial
    Signe Møller-Bisgaard
    Kim Hørslev-Petersen
    Bo Jannik Ejbjerg
    Mikael Boesen
    Merete Lund Hetland
    Robin Christensen
    Jakob Møller
    Niels Steen Krogh
    Kristian Stengaard-Pedersen
    Mikkel Østergaard
    Trials, 16
  • [8] 11 YEARS' FOLLOW-UP OF A DANISH 2-YEAR TREAT-TO-TARGET RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: BASELINE PREDICTORS OF FUNCTIONAL AND RADIOGRAPHIC OUTCOMES
    Hetland, M. L.
    Stengaard-Petersen, K.
    Junker, P.
    Lindegaard, H.
    Ellingsen, T.
    Podenphant, J.
    Skjodt, H.
    Vestergaard, A.
    Ejbjerg, B.
    Jacobsen, S.
    Krogh, N. S.
    Ostergaard, M.
    Horslev-Petersen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 784 - 784
  • [9] Effect of a Non Biologic Treat-to-Target Strategy on MRI-Determined Inflammatory and Destructive Changes in Early Rheumatoid Arthritis - Results from a 2-Year Investigator-Initiated Double-Blind Randomized Controlled Clinical Trial
    Moller-Bisgaard, Signe
    Ejbjerg, Bo Jannik
    Eshed, Iris
    Horslev-Petersen, Kim
    Hetland, Merete Lund
    Jurik, Anne G.
    Vallo, Jorgen
    Thomsen, Henrik
    Torfing, Trine
    Stengaard-Pedersen, Kristian
    Junker, Peter
    Krogh, Niels Steen
    Lottenburger, Tine
    Ellingsen, Torkell
    Andersen, Lis Smedegaard
    Hansen, Ib
    Skjodt, Henrik
    Svendsen, Anders
    Tarp, Ulrik
    Podenphant, Jan
    Pedersen, Jens Kristian
    Lindegaard, Hanne
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016
    Xie, W.
    Li, J.
    Zhang, X.
    Li, G.
    Hao, Y.
    Zhao, J.
    Wang, L.
    Sun, X.
    Fan, Y.
    Zhang, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : 820 - 828
12345